Shopping Cart 0
Cart Subtotal
AED 0

Global PDE Inhibitors Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 10937

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
AED 11671

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 21873

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 21873
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Snapshot

The global PDE Inhibitors market will reach xxx Million USD in 2018 and CAGR xx% 2018-2023. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of PDE Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

PDE5

PDE4

Viagra

Cialis

Levitra

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Hanmi Science Holding

Boehringer Ingelheim

Takeda Pharmaceuticals

Pfizer

Omeros

Anacor Pharmaceuticals

Otsuka

Chiesi Farmaceutici

Verona Pharma

NuSirt Biopharma

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Genitourinary

Cardiovascular Diseases

Neurological Diseases

Dermatological Disorders

Respiratory Diseases

Other Indications

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Content

1 Industry Overview

1.1 PDE Inhibitors Industry

1.1.1 Overview

1.1.2 Development of PDE Inhibitors

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 PDE Inhibitors Market by Type

3.1 By Type

3.1.1 PDE5

3.1.2 PDE4

3.1.3 Viagra

3.1.4 Cialis

3.1.5 Levitra

3.1.6 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.1 Hanmi Science Holding (Company Profile, Sales Data etc.)

4.2 Boehringer Ingelheim (Company Profile, Sales Data etc.)

4.3 Takeda Pharmaceuticals (Company Profile, Sales Data etc.)

4.4 Pfizer (Company Profile, Sales Data etc.)

4.5 Omeros (Company Profile, Sales Data etc.)

4.6 Anacor Pharmaceuticals (Company Profile, Sales Data etc.)

4.7 Otsuka (Company Profile, Sales Data etc.)

4.8 Chiesi Farmaceutici (Company Profile, Sales Data etc.)

4.9 Verona Pharma (Company Profile, Sales Data etc.)

4.10 NuSirt Biopharma (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Market Demand

6.1 Demand Situation

6.1.1 Demand in Genitourinary

6.1.2 Demand in Cardiovascular Diseases

6.1.3 Demand in Neurological Diseases

6.1.4 Demand in Dermatological Disorders

6.1.5 Demand in Respiratory Diseases

6.1.6 Demand in Other Indications

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure PDE Inhibitors Industry Chain Structure

Figure Global PDE Inhibitors Market Growth 2013-2018, by Type, in USD Million

Figure North America PDE Inhibitors Market, by Company, in 2018

Figure Europe PDE Inhibitors Market Market, by Company, in 2018

Figure Asia-Pacific PDE Inhibitors Market Market, by Company, in 2018

Figure South America PDE Inhibitors Market Market, by Company, in 2018

Figure Middle East & Africa PDE Inhibitors Market Market, by Company, in 2018

Figure North America PDE Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Europe PDE Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific PDE Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure South America PDE Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa PDE Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of PDE Inhibitors

Table Application Segment of PDE Inhibitors

Table Global PDE Inhibitors Market 2013-2024, by Application, in USD Million

Table Major Company List of PDE5

Table Major Company List of PDE4

Table Major Company List of Viagra

Table Major Company List of Cialis

Table Major Company List of Levitra

Table Major Company List of Others

Table Global PDE Inhibitors Market 2013-2018, by Type, in USD Million

Table Global PDE Inhibitors Market Forecast 2019-2024, by Type, in USD Million

Table Hanmi Science Holding Overview List

Table PDE Inhibitors Business Operation of Hanmi Science Holding (Sales Revenue, Cost, Gross Margin)

Table Boehringer Ingelheim Overview List

Table PDE Inhibitors Business Operation of Boehringer Ingelheim (Sales Revenue, Cost, Gross Margin)

Table Takeda Pharmaceuticals Overview List

Table PDE Inhibitors Business Operation of Takeda Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

Table Pfizer Overview List

Table PDE Inhibitors Business Operation of Pfizer (Sales Revenue, Cost, Gross Margin)

Table Omeros Overview List

Table PDE Inhibitors Business Operation of Omeros (Sales Revenue, Cost, Gross Margin)

Table Anacor Pharmaceuticals Overview List

Table PDE Inhibitors Business Operation of Anacor Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

Table Otsuka Overview List

Table PDE Inhibitors Business Operation of Otsuka (Sales Revenue, Cost, Gross Margin)

Table Chiesi Farmaceutici Overview List

Table PDE Inhibitors Business Operation of Chiesi Farmaceutici (Sales Revenue, Cost, Gross Margin)

Table Verona Pharma Overview List

Table PDE Inhibitors Business Operation of Verona Pharma (Sales Revenue, Cost, Gross Margin)

Table NuSirt Biopharma Overview List

Table PDE Inhibitors Business Operation of NuSirt Biopharma (Sales Revenue, Cost, Gross Margin)

Table Global PDE Inhibitors Sales Revenue 2013-2018, by Company, in USD Million

Table Global PDE Inhibitors Sales Revenue Share, by Company, in USD Million

Table PDE Inhibitors Demand in Genitourinary, 2013-2018, in USD Million

Table Major Consumers in Genitourinary

Table PDE Inhibitors Demand in Cardiovascular Diseases, 2013-2018, in USD Million

Table Major Consumers in Cardiovascular Diseases

Table PDE Inhibitors Demand in Neurological Diseases, 2013-2018, in USD Million

Table Major Consumers in Neurological Diseases

Table PDE Inhibitors Demand in Dermatological Disorders, 2013-2018, in USD Million

Table Major Consumers in Dermatological Disorders

Table PDE Inhibitors Demand in Respiratory Diseases, 2013-2018, in USD Million

Table Major Consumers in Respiratory Diseases

Table PDE Inhibitors Demand in Other Indications, 2013-2018, in USD Million

Table Major Consumers in Other Indications

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table PDE Inhibitors Demand Forecast 2019-2024, by Application, in USD Million

Table PDE Inhibitors Production 2013-2018, by Region, in USD Million

Table Global PDE Inhibitors Market 2013-2018, by Region, in USD Million

Table Global PDE Inhibitors Market Share 2013-2018, by Region, in USD Million

Table North America PDE Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Europe PDE Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific PDE Inhibitors Market Size 2013-2018, by Country, in USD Million

Table South America PDE Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa PDE Inhibitors Market Size 2013-2018, by Country, in USD Million

Table PDE Inhibitors Market Forecast 2019-2024, by Region, in USD Million

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com